Merrimack Pharmaceuticals, Inc. Gains 212.75%

Wed, Nov 09, 2022 at 07:52 PM
Merrimack Pharmaceuticals, Inc. Gains 212.75%

Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ) soared at $12.51, a gain of 212.8%. On Wed, Nov 09, 2022, MACK:NASDAQ hit a New 2-Week High of $12.51. The stock appeared on our News Catalysts scanner on Wed, Nov 09, 2022 at 12:30 PM in the 'BIOTECH' category. From Wed, Oct 26, 2022, the stock recorded 80.00% Up Days and 36.36% Green Days

About Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ)

Merrimack Pharmaceuticals Inc is a biotechnology company. It discovers, develops, and commercializes innovative medicines consisting of novel therapeutics paired with diagnostics to treat various types of cancer.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.